Investors Purchase High Volume of Call Options on Boston Scientific Corp. (BSX)
Boston Scientific Corp. (NYSE:BSX) was the target of some unusual options trading activity on Tuesday. Traders acquired 21,271 call options on the company, AmericanBankingNews.com reports. This is an increase of approximately 149% compared to the average daily volume of 8,553 call options.
Several analysts have recently commented on the stock. Analysts at Piper Jaffray upgraded shares of Boston Scientific Corp. from a “neutral” rating to an “overweight” rating in a research note to investors on Tuesday, January 21st. They now have a $18.00 price target on the stock, up previously from $12.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Boston Scientific Corp. in a research note to investors on Tuesday, January 14th. They now have a $14.00 price target on the stock. Finally, analysts at Barclays raised their price target on shares of Boston Scientific Corp. from $13.00 to $14.00 in a research note to investors on Thursday, January 9th. They now have an “overweight” rating on the stock. Twelve investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $11.59.
Shares of Boston Scientific Corp. (NYSE:BSX) opened at 13.28 on Wednesday. Boston Scientific Corp. has a one year low of $7.07 and a one year high of $14.08. The stock’s 50-day moving average is $12.44 and its 200-day moving average is $11.67. The company’s market cap is $17.732 billion.
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.